How can targeted inhibitor use be optimized for maximum efficacy in pediatric low-grade glioma?

While targeted inhibitors show tremendous promise, the abstract identifies ongoing challenges about optimal usage strategies. This gap affects treatment protocols and patient outcomes in a chronic pediatric condition.

Gap type: open_question Source paper: Pediatric low-grade glioma: State-of-the-art and ongoing challenges. (None, None, PMID:37944912)